BILL CARNEY AND COMPANY for GEONUCLIDES, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
U-233 processing at ORNL and potential funding opportunities of the process Assessment of the viability of reinstating a DOE program to extract certain isotopes from Government-owned stockpiled material in order to complete testing on select patients in an effort to determine the efficacy of beta particle therapies in the treatment of cancer. To date, no specific request for any legislation has been made to Congressional members, staff or a DOE office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM CARNEY New | — |
Medical/Disease Research/Clinical Labs MED
U-233 processing at ORNL and potential funding opportunities of the process Assessment of the viability of reinstating a DOE program to extract certain isotopes from Government-owned stockpiled material in order to complete testing on select patients in an effort to determine the efficacy of beta particle therapies in the treatment of cancer. To date, no specific request for any legislation has been made to Congressional members, staff or a DOE office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM CARNEY New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.